In severe gram-positive infections

Prescrire International

Volumn 12, Issue 64, 2003, Pages 46-48

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMINE OXIDASE (FLAVIN CONTAINING); AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFPODOXIME; CEFTRIAXONE; DALFOPRISTIN; DICLOXACILLIN; DOPAMINE RECEPTOR STIMULATING AGENT; FLUCLOXACILLIN; HYPERTENSIVE AGENT; LINEZOLID; MACROLIDE; OXACILLIN; OXAZOLIDINONE DERIVATIVE; PETHIDINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINUPRISTIN; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; TEICOPLANIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VANCOMYCIN;

ANEMIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOOD TOXICITY; CANDIDIASIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DRUG INDICATION; ENZYME INHIBITION; GRAM POSITIVE BACTERIUM; HEADACHE; HOSPITAL INFECTION; HUMAN; HYPERTENSIVE CRISIS; INSOMNIA; MULTIDRUG RESISTANCE; NAUSEA; NONHUMAN; PNEUMONIA; PSEUDOMEMBRANOUS COLITIS; RASH; SEROTONIN SYNDROME; SKIN INFECTION; SOFT TISSUE INFECTION; THROMBOCYTOPENIA; VERTIGO; VOMITING;

EID: 0038277174     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. "Hospital acquired pneumonia". In: "Martindale The Complete Drug Reference" 33rd ed. The Pharmaceutical Press, London 2002: 136.
2. "Skin infections" + "Staphylococcal infections". In: "Martindale The Complete Drug Reference" 33rd ed. The Pharmaceutical Press, London 2002: 140-141.
3. Prescrire Editorial Staff "Fluoroquinolones in ambulatory ENT and respiratory tract infections" Prescr Int 2003 ; 12 (63): 26-27.
4. Prescrire Rédaction "quinupristine + dalfopristine (Synercid°)" Rev Prescr 2001 ; 21 (216): 263-266.
5. Mandell LA et Campbell GD "Nosocomial pneumonia guidelines" Chest 1998; 113 (suppl.): 188-193.
6. Lynch JP III "Hospital acquired pneumonia" Chest 2001 ; 119 (suppl.): 373-384.
7. Food and Drug Administration-Center for Drug Evaluation and Research "Application number: 21-130, 21-131, 21-132-Statistical review and evaluation" 10 April 2000: 115 pages.
8. Perry CM et Jarvis B "Linezolid - A review of its use in the management of serious gram-positive infections" Drugs 2001 ; 61 (4): 525- 551.
9. Rubinstein E et al. "Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study" Clin Infect Dis 2001 ; 32: 402-412.
10. Stevens DL et al. "Randomized comparison of linezolid (PNU-100766) versus oxacillindicloxacillin for treatment of complicated skin and soft tissue infections" Antimicrob Agents Chemother 2000 ; 44 (12): 3408-3413.
11. Stevens DL et al. "Linezolid versus vancomycin for the treatment of methicillin-resistant staphylococcus aureus infections" Clin Infect Dis 2002 ; 34: 1481-1490.
12. Fung HB et al. "Linezolid: an oxazolidinone antimicrobial agent" Clin Ther 2001 ; 23 (3): 356-391.
13. French agency for health product safety "Résumé des caractéristiques des produits - Zyvoxid 2 mg/ml, solution pour perfusion" 31 August 2001 ; 16 pages.
14. Kuter DJ et al. "Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid" Pharmacotherapy 2001 ; 21 (8): 1010-1013.
15. "Reminder: linezolid and myelosuppression" Curr Probl Pharmacovig 2001 ; 27: 14.
16. Gonzales RD et al. "Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid" Lancet 2001 ; 357: 1179.
17. Corallo CE and Pauli AE "Linezolid-induced neuropathy" Med J Austr 2002 ; 177: 332.